Frequencies for first 10,000 rows of med10 variable in nhamcsed2014 dataset : Medication 10 | Freq. Percent Cum. ----------------------------------------+----------------------------------- NO ENTRY MADE | 9,811 98.11 98.11 MYCOPHENOLATE MOFETIL | 1 0.01 98.12 PROTONIX | 1 0.01 98.13 KEPPRA | 2 0.02 98.15 ENOXAPARIN SODIUM | 1 0.01 98.16 ACETAMINOPHEN | 1 0.01 98.17 NEXIUM | 1 0.01 98.18 METOPROLOL TARTRATE | 1 0.01 98.19 DORZOLAMIDE AND TIMOLOL | 1 0.01 98.20 GLUCAGEN | 1 0.01 98.21 DUONEB | 2 0.02 98.23 APRESOLINE | 1 0.01 98.24 AQUAPHOR | 1 0.01 98.25 ASPIRIN | 6 0.06 98.31 ATARAX | 1 0.01 98.32 ATIVAN | 1 0.01 98.33 HEPARIN SODIUM | 2 0.02 98.35 BACITRACIN | 1 0.01 98.36 NAMENDA | 2 0.02 98.38 SENNA-S | 1 0.01 98.39 BICITRA | 1 0.01 98.40 DULOXETINE | 1 0.01 98.41 DALTEPARIN SODIUM | 1 0.01 98.42 LIDOCAINE/PRILOCAINE | 1 0.01 98.43 FLUTICASON-SALMETEROL | 1 0.01 98.44 AZILECT | 1 0.01 98.45 FLECAINIDE | 1 0.01 98.46 TELMISARTAN | 1 0.01 98.47 COLACE | 1 0.01 98.48 VITAMIN D3 | 1 0.01 98.49 HYALURONIC ACID | 1 0.01 98.50 SALINE LOCK | 1 0.01 98.51 DECADRON | 1 0.01 98.52 MYOVIEW | 1 0.01 98.53 DEXTROSE | 2 0.02 98.55 COLLAGENASE OINTMENT | 1 0.01 98.56 DIPHENHYDRAMINE | 1 0.01 98.57 DOCUSATE | 1 0.01 98.58 DOXYCYCLINE | 1 0.01 98.59 XARELTO | 1 0.01 98.60 ETHAMBUTOL | 1 0.01 98.61 PANTOPRAZOLE | 1 0.01 98.62 PERCOCET | 3 0.03 98.65 SULFAMETHOXAZOLE-TRIMETHOPRIM | 1 0.01 98.66 FLEXERIL | 1 0.01 98.67 LISINOPRIL-HYDROCHLOROTHIAZIDE | 1 0.01 98.68 FUROSEMIDE | 1 0.01 98.69 GLUCOTROL | 1 0.01 98.70 HEPARIN | 2 0.02 98.72 HYDROCODONE | 2 0.02 98.74 HYDRODIURIL | 1 0.01 98.75 HYDROMORPHONE | 1 0.01 98.76 INSULIN | 1 0.01 98.77 K-TAB | 1 0.01 98.78 KLOR-CON | 1 0.01 98.79 LORAZEPAM | 1 0.01 98.80 MAALOX | 1 0.01 98.81 MAGNESIUM CITRATE | 1 0.01 98.82 MAGNESIUM SULFATE | 3 0.03 98.85 MAGNESIUM/ALUMINUM HYDROXIDE | 1 0.01 98.86 MECLIZINE | 1 0.01 98.87 METOPROLOL | 3 0.03 98.90 METRONIDAZOLE | 1 0.01 98.91 MILK OF MAGNESIA | 1 0.01 98.92 MORPHINE | 2 0.02 98.94 MULTIVITAMIN | 1 0.01 98.95 PHENERGAN | 1 0.01 98.96 PHENYLEPHRINE | 1 0.01 98.97 POTASSIUM | 1 0.01 98.98 POTASSIUM CHLORIDE | 1 0.01 98.99 PREDNISONE | 4 0.04 99.03 PROCARDIA | 1 0.01 99.04 PROMETHAZINE | 2 0.02 99.06 REGLAN | 1 0.01 99.07 RESTORIL | 1 0.01 99.08 SALINE | 2 0.02 99.10 SODIUM CHLORIDE | 2 0.02 99.12 SOLU-MEDROL | 1 0.01 99.13 SPIRONOLACTONE | 1 0.01 99.14 SUBLIMAZE | 1 0.01 99.15 SYNTHROID | 1 0.01 99.16 THIAMINE | 1 0.01 99.17 TYLENOL | 4 0.04 99.21 VANCOCIN | 1 0.01 99.22 VANCOMYCIN | 2 0.02 99.24 VITAMIN B COMPLEX | 1 0.01 99.25 VITAMIN B-12 | 1 0.01 99.26 VITAMIN D | 1 0.01 99.27 WARFARIN | 1 0.01 99.28 XANAX | 2 0.02 99.30 POLYETHYLENE GLYCOL | 2 0.02 99.32 ZANTAC | 1 0.01 99.33 NORMAL SALINE | 3 0.03 99.36 AUGMENTIN | 1 0.01 99.37 INFLUENZA VIRUS VACC | 1 0.01 99.38 ISOVUE | 1 0.01 99.39 K-DUR | 1 0.01 99.40 LACTATED RINGER'S | 2 0.02 99.42 OMNIPAQUE | 1 0.01 99.43 PEPCID | 1 0.01 99.44 PIPERACILLIN | 1 0.01 99.45 ROCEPHIN | 1 0.01 99.46 NIFEDIPINE | 1 0.01 99.47 ALPRAZOLAM | 1 0.01 99.48 GLIPIZIDE | 1 0.01 99.49 OMEPRAZOLE | 2 0.02 99.51 BIAXIN | 1 0.01 99.52 ZOFRAN | 3 0.03 99.55 CLARITHROMYCIN | 1 0.01 99.56 ONDANSETRON | 2 0.02 99.58 QUINAPRIL | 1 0.01 99.59 TORADOL | 2 0.02 99.61 LISINOPRIL | 3 0.03 99.64 ARTIFICIAL TEAR SOLUTION | 1 0.01 99.65 PERIDEX | 1 0.01 99.66 ZITHROMAX | 1 0.01 99.67 NORVASC | 1 0.01 99.68 GEMFIBROZIL | 1 0.01 99.69 AZITHROMYCIN | 2 0.02 99.71 LORATADINE | 1 0.01 99.72 PHOSLO | 1 0.01 99.73 CEFOXITIN | 1 0.01 99.74 AMLODIPINE | 2 0.02 99.76 NEURONTIN | 1 0.01 99.77 RISPERIDONE | 1 0.01 99.78 LOVENOX | 3 0.03 99.81 RISPERDAL | 1 0.01 99.82 ULTRAM | 1 0.01 99.83 PROPHYLAXIS | 1 0.01 99.84 METFORMIN | 2 0.02 99.86 ZOSYN | 1 0.01 99.87 DOCUSATE SODIUM | 1 0.01 99.88 TRAMADOL | 1 0.01 99.89 ETOMIDATE | 1 0.01 99.90 LANSOPRAZOLE | 2 0.02 99.92 AMARYL | 1 0.01 99.93 LIPITOR | 1 0.01 99.94 LOSARTAN | 1 0.01 99.95 ATORVASTATIN | 2 0.02 99.97 CALCITRIOL | 1 0.01 99.98 MIRALAX | 1 0.01 99.99 ALBUTEROL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 11 Apr 2017